Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIABETES.51.3.813PMID 11872685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging.

  2001cited by this paper
• In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus

  1999cited by this paper
• In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

  1999cited by this paper
• Reduced coronary NO production in conscious dogs after the development of alloxan-induced diabetes.

  1999cited by this paper
• Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

  1999cited by this paper
• Diabetic cardiomyopathy

  1998cited by this paper
• Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.

  1998influential reference
• Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk.

  1998cited by this paper
• Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.

  1997cited by this paper
• Effects of cardiac sympathetic innervation on coronary blood flow.

  1997cited by this paper
• Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.

  1997cited by this paper
• Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction.

  1996cited by this paper
• Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

  1995influential reference
• Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs.

  1995cited by this paper
• Loss of flow-dependent coronary artery dilatation in patients with hypertension.

  1995cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Silent Coronary Artery Disease in Diabetic Patients With Cardiac Autonomic Neuropathy

  1994cited by this paper
• Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus

  1993cited by this paper
• Coronary Endothelial Injury After Cardiopulmonary Bypass and Ischemic Cardioplegia Is Mediated by Oxygen‐Derived Free Radicals

  1993cited by this paper
• Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.

  1993cited by this paper
• Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

  1993cited by this paper
• Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.

  1992cited by this paper
• Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes.

  1992cited by this paper
• Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells.

  1992cited by this paper
• Myocardial Metabolism in Type 1 Diabetic Patients Without Coronary Artery Disease

  1991cited by this paper
• Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta.

  1991cited by this paper
• Autonomic Dysfunction and Silent Myocardial Ischaemia on Exercise Testing in Diabetes Mellitus

  1990cited by this paper
• Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action?

  1989cited by this paper
• Effect of diabetes on metabolic coronary dilatation in the rat.

  1989cited by this paper
• Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.

  1989cited by this paper
• Marked Reduction of Free Radical Generation and Contractile Dysfunction by Antioxidant Therapy Begun at the Time of Reperfusion Evidence That Myocardial "Stunning" Is a Manifestation of Reperfusion Injury

  1989cited by this paper
• Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium.

  1989cited by this paper
• Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta.

  1988cited by this paper
• Delineation of the distribution of beta-adrenergic receptor subtypes in canine myocardium.

  1988cited by this paper
• Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.

  1988cited by this paper
• Evidence For a Role of Iron‐Catalyzed Oxidants in Functional and Metabolic Stunning in the Canine Heart

  1988cited by this paper
• The role of iron in ascorbate-dependent deoxyribose degradation. Evidence consistent with a site-specific hydroxyl radical generation caused by iron ions bound to the deoxyribose molecule

  1987cited by this paper
• The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction.

  1987cited by this paper
• Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

  1986cited by this paper
• Flow-induced release of endothelium-derived relaxing factor.

  1986cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts.

  1986cited by this paper
• Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.

  1986cited by this paper
• Diabetic cardiomyopathy.

  1985cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man

  1979cited by this paper
• Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron‐Loaded Subjects

  1979cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Evidence for cardiomyopathy in familial diabetes mellitus.

  1977cited by this paper
• Diabetic cardiomyopathy.

  1974cited by this paper

• Ferroptosis and pyroptosis: Mediating mechanisms of the cGAS/STING pathway and therapeutic strategies in heart failure.

  2025cites this paper
• Redox Regulation of Microvascular Physiology and Pathophysiology: Insights into Therapeutic Strategies and Limitations

  2025cites this paper
• Mechanism of ferroptosis in heart failure: The role of the RAGE/TLR4-JNK1/2 pathway in cardiomyocyte ferroptosis and intervention strategies.

  2025cites this paper
• Natural products and ferroptosis: A novel approach for heart failure management.

  2025cites this paper
• Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases

  2025cites this paper
• Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities

  2023cites this paper
• Roles of Ferroptosis in Cardiovascular Diseases

  2022cites this paper
• Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator

  2021cites this paper
• Novel insights into ferroptosis: Implications for age-related diseases

  2020cites this paper
• Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis.

  2020cites this paper
• lncRNA FENDRR Exhibits Anti-Fibrotic Activity in Pulmonary Fibrosis.

  2019cites this paper
• Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.

  2019cites this paper
• Complications cardiovasculaires macro-angiopathiques et insuffisance cardiaque chez le diabétique

  2019cites this paper
• FERROPTOSIS AND ITS POTENTIAL ROLE IN CARDIOVASCULAR DISEASES

  2019cites this paper
• Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis.

  2018cites this paper
• Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing

  2017cites this paper
• Serum ferritin and risk for new‐onset heart failure and cardiovascular events in the community

  2017cites this paper
• MRI-measured myocardial iron load in patients with severe diabetic heart failure.

  2017cites this paper
• Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

  2015cites this paper
• Chapitre 13 – Complications cardiovasculaires macroangiopathiques et insuffisance cardiaque chez le diabétique

  2014cites this paper
• The glycation site specificity of human serum transferrin is a determinant for transferrin's functional impairment under elevated glycaemic conditions.

  2014cites this paper
• Iron overload in nonalcoholic steatohepatitis.

  2011cites this paper
• Chapitre 12 – Complications cardiovasculaires macroangiopathiques et insuffisance cardiaque chez le diabétique

  2010cites this paper
• It is not yet the time to stop screening diabetic patients for silent myocardial ischaemia.

  2010cites this paper
• Synthetic and natural iron chelators: therapeutic potential and clinical use.

  2009cites this paper
• N‐terminal pro‐B‐type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients

  2009cites this paper
• Correlation Between the Serum Bilirubin Level and the Coronary Microvascular Integrity in Diabetic Patients

  2008cites this paper
• Iron Perturbations in Human Non-Alcoholic Fatty Liver Disease (NAFLD): Clinical Relevance and Molecular Mechanisms

  2008cites this paper
• Resistencia a la insulina y aterosclerosis. Impacto del estrés oxidativo en la función endotelial

  2008cites this paper
• Insulin Resistance and Atherosclerosis. The Impact of Oxidative Stress on Endothelial Function

  2008cites this paper
• Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?

  2007cites this paper
• L'endothéliopathie : Son risque et rôle des facteurs métaboliques

  2007cites this paper
• Perfusion and Function in the Normal and Abnormal Heart

  2007cites this paper
• Antioxidant N-acetylcysteine restores systemic nitric oxide availability and corrects depressions in arterial blood pressure and heart rate in diabetic rats

  2006cites this paper
• Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus

  2005cites this paper
• Large and micro coronary vascular involvement in diabetes.

  2005cites this paper
• Purified human plasma glycosaminoglycans limit oxidative injury induced by iron plus ascorbate in skin fibroblast cultures.

  2005cites this paper
• Therapy Insight: heart disease and the insulin-resistant patient

  2005cites this paper
• [Endothelial dysfunction in patients with diabetes: identification, pathogenesis and treatment].

  2005cites this paper
• Hierro, resistencia a la insulina y riesgo cardiovascular

  2004cites this paper
• Desferrioxamine modulates chemically induced T helper 2‐mediated autoimmunity in the rat

  2004cites this paper
• Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors.

  2004cites this paper
• Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis.

  2003cites this paper
• Insulin resistance and impaired regulation of hemodynamic parameters

  2003cites this paper
• Cardiac autonomic dysinnervation and myocardial blood flow in long‐term Type 1 diabetic patients

  2003cites this paper
• L'endothélium vasculaire : un organe cible du diabète

  2002cites this paper
• Cross-talk between iron metabolism and diabetes.

  2002cites this paper
• Perspectives in Diabetes Cross-Talk Between Iron Metabolism and Diabetes

  2002cites this paper